{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:57:15Z","timestamp":1791298635072,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19de0107002"],"award-info":[{"award-number":["JP19de0107002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01955-5","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:10:40Z","timestamp":1761963040000},"page":"5661-5672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated plasma GFAP levels in MCI link APOE \u03b54 allele with impaired gait speed"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3475-9686","authenticated-orcid":false,"given":"Ryota","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"issue":"19 Pt 2","key":"1955_CR1","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1212\/01.wnl.0000304038.37421.cc","volume":"70","author":"S Cosentino","year":"2008","unstructured":"Cosentino S, Scarmeas N, Helzner E, Glymour MM, Brandt J, Albert M, et al. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology. 2008;70(19 Pt 2):1842\u20139.","journal-title":"Neurology"},{"key":"1955_CR2","doi-asserted-by":"crossref","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and alzheimer disease meta analysis consortium. JAMA. 1997;278(16):1349\u201356.","DOI":"10.1001\/jama.1997.03550160069041"},{"issue":"11","key":"1955_CR3","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/gerona\/glt115","volume":"68","author":"J Verghese","year":"2013","unstructured":"Verghese J, Holtzer R, Wang C, Katz MJ, Barzilai N, Lipton RB. Role of APOE genotype in gait decline and disability in aging. J Gerontol A Biol Sci Med Sci. 2013;68(11):1395\u2013401.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"1955_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/WAD.0b013e31818877b5","volume":"23","author":"AS Buchman","year":"2009","unstructured":"Buchman AS, Boyle PA, Wilson RS, Beck TL, Kelly JF, Bennett DA. Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons. Alzheimer Dis Assoc Disord. 2009;23(1):63\u20139.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"12","key":"1955_CR5","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/gerona\/glx075","volume":"72","author":"R Sakurai","year":"2017","unstructured":"Sakurai R, Montero-Odasso M. Apolipoprotein E4 allele and gait performance in mild cognitive impairment: results from the gait and brain study. J Gerontol A Biol Sci Med Sci. 2017;72(12):1676\u201382.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"11","key":"1955_CR6","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1111\/j.1532-5415.2012.04209.x","volume":"60","author":"M Montero-Odasso","year":"2012","unstructured":"Montero-Odasso M, Verghese J, Beauchet O, Hausdorff JM. Gait and cognition: a complementary approach to understanding brain function and the risk of falling. J Am Geriatr Soc. 2012;60(11):2127\u201336.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"1955_CR7","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/gerona\/glu093","volume":"69","author":"R Sakurai","year":"2014","unstructured":"Sakurai R, Fujiwara Y, Yasunaga M, Takeuchi R, Murayama Y, Ohba H, et al. Regional cerebral glucose metabolism and gait speed in healthy community-dwelling older women. J Gerontol A Biol Sci Med Sci. 2014;69(12):1519\u201327.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"1955_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"1955_CR9","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1007\/s00415-018-9100-8","volume":"266","author":"EW Lim","year":"2019","unstructured":"Lim EW, Aarsland D, Ffytche D, Taddei RN, van Wamelen DJ, Wan YM, et al. Amyloid-\u03b2 and Parkinson\u2019s disease. J Neurol. 2019;266(11):2605\u201319.","journal-title":"J Neurol"},{"key":"1955_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.599384","volume":"11","author":"J Ganguly","year":"2020","unstructured":"Ganguly J, Jog M. Tauopathy and movement disorders-unveiling the chameleons and mimics. Front Neurol. 2020;11:599384.","journal-title":"Front Neurol"},{"issue":"1","key":"1955_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1212\/WNL.0000000000002235","volume":"86","author":"N Del Campo","year":"2016","unstructured":"Del Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, et al. Relationship of regional brain \u03b2-amyloid to gait speed. Neurology. 2016;86(1):36\u201343.","journal-title":"Neurology"},{"issue":"1","key":"1955_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-023-01221-w","volume":"15","author":"M Malek-Ahmadi","year":"2023","unstructured":"Malek-Ahmadi M, Su Y, Ghisays V, Luo J, Devadas V, Chen Y, et al. Plasma NfL is associated with the APOE \u03b54 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults. Alzheimers Res Ther. 2023;15(1):74.","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"1955_CR13","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019;90(8):870\u201381.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"1955_CR14","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/mds.28206","volume":"35","author":"B Mollenhauer","year":"2020","unstructured":"Mollenhauer B, Dakna M, Kruse N, Galasko D, Foroud T, Zetterberg H, et al. Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression. Mov Disord. 2020;35(11):1999\u20132008.","journal-title":"Mov Disord"},{"issue":"6","key":"1955_CR15","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1002\/alz.13804","volume":"20","author":"JG Cooper","year":"2024","unstructured":"Cooper JG, Ghodsi M, Stukas S, Leach S, Brooks-Wilson A, Wellington CL. APOE \u03b54 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors. Alzheimers Dement. 2024;20(6):4373\u201380.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1955_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae396","volume":"6","author":"F Leipp","year":"2024","unstructured":"Leipp F, Vialaret J, Mohaupt P, Coppens S, Jaffuel A, Niehoff AC, et al. Glial fibrillary acidic protein in Alzheimer\u2019s disease: a narrative review. Brain Commun. 2024;6(6):fcae396.","journal-title":"Brain Commun"},{"key":"1955_CR17","doi-asserted-by":"crossref","unstructured":"Che N, Ou R, Li C, Zhang L, Wei Q, Wang S, et al. Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson\u2019s disease. NPJ Park Dis. 2024;10(1):48.","DOI":"10.1038\/s41531-024-00664-8"},{"key":"1955_CR18","doi-asserted-by":"crossref","unstructured":"Ali F, Syrjanen JA, Figdore DJ, Kremers WK, Mielke MM, Jack CR, et al. Association of plasma biomarkers of Alzheimer\u2019s pathology and neurodegeneration with gait performance in older adults. Commun Med. 2025;5(1):19.","DOI":"10.1038\/s43856-024-00713-6"},{"key":"1955_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00247","volume":"11","author":"R Sakurai","year":"2019","unstructured":"Sakurai R, Watanabe Y, Osuka Y, Taniguchi Y, Kawai H, Kim H, et al. Overlap between apolipoprotein E\u03b54 allele and slowing gait results in cognitive impairment. Front Aging Neurosci. 2019;11:247.","journal-title":"Front Aging Neurosci"},{"key":"1955_CR20","doi-asserted-by":"crossref","unstructured":"Jayakody O, Breslin M, Srikanth V, Callisaya M. Gait characteristics and cognitive decline: a longitudinal population-based study. J Alzheimers Dis. 2019;71(s1):S5\u2013S14.","DOI":"10.3233\/JAD-181157"},{"issue":"4","key":"1955_CR21","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/alz.13740","volume":"20","author":"R Sakurai","year":"2024","unstructured":"Sakurai R, Pieruccini-Faria F, Cornish B, Fraser J, Binns MA, Beaton D, et al. Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study. Alzheimers Dement. 2024;20(4):2968\u201379.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1955_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-141-2-200407200-00013","volume":"141","author":"Y Song","year":"2004","unstructured":"Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med. 2004;141(2):137\u201347.","journal-title":"Ann Intern Med"},{"key":"1955_CR23","doi-asserted-by":"crossref","unstructured":"Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106\u201318.","DOI":"10.1038\/nrneurol.2012.263"},{"issue":"4","key":"1955_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.14283\/jpad.2021.29","volume":"8","author":"T Sugimoto","year":"2021","unstructured":"Sugimoto T, Sakurai T, Akatsu H, Doi T, Fujiwara Y, Hirakawa A, et al. The japan-multimodal intervention trial for prevention of dementia (J-MINT): the study protocol for an 18-month, multicenter, randomized, controlled trial. J Prev Alzheimers Dis. 2021;8(4):465\u201376.","journal-title":"J Prev Alzheimers Dis"},{"issue":"6","key":"1955_CR25","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/alz.13838","volume":"20","author":"T Sakurai","year":"2024","unstructured":"Sakurai T, Sugimoto T, Akatsu H, Doi T, Fujiwara Y, Hirakawa A, et al. Japan-multimodal intervention trial for the prevention of dementia: a randomized controlled trial. Alzheimers Dement. 2024;20(6):3918\u201330.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1955_CR26","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1111\/ggi.13079","volume":"17","author":"H Shimada","year":"2017","unstructured":"Shimada H, Makizako H, Park H, Doi T, Lee S. Validity of the National Center for Geriatrics and Gerontology-Functional Assessment Tool and Mini-Mental State Examination for detecting the incidence of dementia in older Japanese adults. Geriatr Gerontol Int. 2017;17(12):2383\u20138.","journal-title":"Geriatr Gerontol Int"},{"key":"1955_CR27","doi-asserted-by":"crossref","unstructured":"Petersen RC. Clinical practice. Mild cognitive impairment. N Engl J Med. 2011;364(23):2227\u201334.","DOI":"10.1056\/NEJMcp0910237"},{"issue":"3","key":"1955_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","volume":"256","author":"B Winblad","year":"2004","unstructured":"Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment\u2013beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240\u20136.","journal-title":"J Intern Med"},{"issue":"7691","key":"1955_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dor\u00e9 V, et al. High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature. 2018;554(7691):249\u201354.","journal-title":"Nature"},{"issue":"3","key":"1955_CR30","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3233\/JAD-200475","volume":"77","author":"YY Lim","year":"2020","unstructured":"Lim YY, Maruff P, Kaneko N, Doecke J, Fowler C, Villemagne VL, et al. Plasma amyloid-\u03b2 biomarker associated with cognitive decline in preclinical Alzheimer\u2019s disease. J Alzheimers Dis. 2020;77(3):1057\u201365.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1955_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-017-0206-8","volume":"12","author":"H Tatebe","year":"2017","unstructured":"Tatebe H, Kasai T, Ohmichi T, Kishi Y, Kakeya T, Waragai M, et al. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer\u2019s disease and down syndrome. Mol Neurodegener. 2017;12(1):63.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"1955_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211575","volume":"14","author":"M Shinomoto","year":"2019","unstructured":"Shinomoto M, Kasai T, Tatebe H, Kondo M, Ohmichi T, Morimoto M, et al. Plasma neurofilament light chain: a potential prognostic biomarker of dementia in adult Down syndrome patients. PLoS ONE. 2019;14(4):e0211575.","journal-title":"PLoS ONE"},{"issue":"1","key":"1955_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13195-021-00939-9","volume":"13","author":"S Bayoumy","year":"2021","unstructured":"Bayoumy S, Verberk IMW, den Dulk B, Hussainali Z, Zwan M, van der Flier WM, et al. Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231. Alzheimers Res Ther. 2021;13(1):198.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1955_CR34","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","volume":"12","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Janelidze S, Al Khleifat A, Leuzy A, van der Ende EL, Karikari TK, et al. A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun. 2021;12(1):3400.","journal-title":"Nat Commun"},{"issue":"1","key":"1955_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","volume":"14","author":"S Baiardi","year":"2022","unstructured":"Baiardi S, Quadalti C, Mammana A, Dellavalle S, Zenesini C, Sambati L, et al. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias. Alzheimers Res Ther. 2022;14(1):153.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"1955_CR36","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85-94.","journal-title":"J Gerontol"},{"issue":"2","key":"1955_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1519\/00139143-200831020-00002","volume":"31","author":"RW Bohannon","year":"2008","unstructured":"Bohannon RW. Population representative gait speed and its determinants. J Geriatr Phys Ther. 2008;31(2):49\u201352.","journal-title":"J Geriatr Phys Ther"},{"issue":"8","key":"1955_CR38","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1212\/WNL.0000000000000717","volume":"83","author":"J Verghese","year":"2014","unstructured":"Verghese J, Annweiler C, Ayers E, Barzilai N, Beauchet O, Bennett DA, et al. Motoric cognitive risk syndrome: multicountry prevalence and dementia risk. Neurology. 2014;83(8):718\u201326.","journal-title":"Neurology"},{"issue":"4","key":"1955_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000209965","volume":"27","author":"S Villeneuve","year":"2009","unstructured":"Villeneuve S, Belleville S, Massoud F, Bocti C, Gauthier S. Impact of vascular risk factors and diseases on cognition in persons with mild cognitive impairment. Dement Geriatr Cogn Disord. 2009;27(4):375\u201381.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"1955_CR40","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/alz.13540","volume":"20","author":"S Raghavan","year":"2024","unstructured":"Raghavan S, Przybelski SA, Lesnick TG, Fought AJ, Reid RI, Gebre RK, et al. Vascular risk, gait, behavioral, and plasma indicators of VCID. Alzheimers Dement. 2024;20(2):1201\u201313.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1955_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/ana.25542","volume":"86","author":"MP Pase","year":"2019","unstructured":"Pase MP, Himali JJ, Aparicio HJ, Romero JR, Satizabal CL, Maillard P, et al. Plasma total-tau as a biomarker of stroke risk in the community. Ann Neurol. 2019;86(3):463\u20137.","journal-title":"Ann Neurol"},{"key":"1955_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.expneurol.2012.10.007","volume":"239","author":"R Medeiros","year":"2013","unstructured":"Medeiros R, LaFerla FM. Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol. 2013;239:133\u20138.","journal-title":"Exp Neurol"},{"issue":"1","key":"1955_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/2394-8108.178546","volume":"2","author":"OY Glushakova","year":"2016","unstructured":"Glushakova OY, Glushakov AV, Miller ER, Valadka AB, Hayes RL. Biomarkers for acute diagnosis and management of stroke in neurointensive care units. Brain Circ. 2016;2(1):28\u201347.","journal-title":"Brain Circ"},{"issue":"2","key":"1955_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molmed.2018.11.006","volume":"25","author":"SF Carter","year":"2019","unstructured":"Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER. Astrocyte biomarkers in Alzheimer\u2019s disease. Trends Mol Med. 2019;25(2):77\u201395.","journal-title":"Trends Mol Med"},{"key":"1955_CR45","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.nicl.2017.04.024","volume":"15","author":"AM Cardenas","year":"2017","unstructured":"Cardenas AM, Sarlls JE, Kwan JY, Bageac D, Gala ZS, Danielian LE, et al. Pathology of callosal damage in ALS: an ex-vivo, 7T diffusion tensor MRI study. NeuroImage: Clinical. 2017;15:200\u20138.","journal-title":"NeuroImage: Clinical"},{"key":"1955_CR46","doi-asserted-by":"crossref","unstructured":"Saraste M, Bezukladova S, Matilainen M, Sucksdorff M, Kuhle J, Leppert D, et al. Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI.\u00a0Mult Scler\u00a0Relat Dis. 2021;50:102810.","DOI":"10.1016\/j.msard.2021.102810"},{"issue":"9","key":"1955_CR47","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/gerona\/glx240","volume":"73","author":"AMV Wennberg","year":"2018","unstructured":"Wennberg AMV, Lesnick TG, Schwarz CG, Savica R, Hagen CE, Roberts RO, et al. Longitudinal association between brain amyloid-beta and gait in the Mayo Clinic Study of Aging. J Gerontol A Biol Sci Med Sci. 2018;73(9):1244\u201350.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"1955_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaneurol.2016.3474","volume":"74","author":"NK Nadkarni","year":"2017","unstructured":"Nadkarni NK, Perera S, Snitz BE, Mathis CA, Price J, Williamson JD, et al. Association of brain amyloid-\u03b2 with slow gait in elderly individuals without dementia: influence of cognition and apolipoprotein E \u03b54 genotype. JAMA Neurol. 2017;74(1):82\u201390.","journal-title":"JAMA Neurol"},{"issue":"22","key":"1955_CR49","doi-asserted-by":"publisher","first-page":"e2282","DOI":"10.1212\/WNL.0000000000200287","volume":"98","author":"KA Josephs","year":"2022","unstructured":"Josephs KA, Weigand SD, Whitwell JL. Characterizing amyloid-positive individuals with normal tau PET levels after 5 years: an ADNI study. Neurology. 2022;98(22):e2282\u201392.","journal-title":"Neurology"},{"issue":"2","key":"1955_CR50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrneurol.2014.257","volume":"11","author":"A Nordberg","year":"2015","unstructured":"Nordberg A. Dementia in 2014. Towards early diagnosis in Alzheimer disease. Nat Rev Neurol. 2015;11(2):69\u201370.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"1955_CR51","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","volume":"29","author":"B Bellaver","year":"2023","unstructured":"Bellaver B, Povala G, Ferreira PCL, Ferrari-Souza JP, Leffa DT, Lussier FZ, et al. Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease. Nat Med. 2023;29(7):1775\u201381.","journal-title":"Nat Med"},{"key":"1955_CR52","doi-asserted-by":"crossref","unstructured":"Sakurai R, Ishii K, Yasunaga M, Takeuchi R, Murayama Y, Sakuma N, et al. The neural substrate of gait and executive function relationship in elderly women: a PET study. Geriatr Gerontol Int. 2017;17(11):1873\u201380.","DOI":"10.1111\/ggi.12982"},{"key":"1955_CR53","doi-asserted-by":"crossref","unstructured":"Okoro CA, Zhong Y, Ford ES, Balluz LS, Strine TW, Mokdad AH. Association between the metabolic syndrome and its components and gait speed among U.S. adults aged 50 years and older: a cross-sectional analysis. BMC Public Health. 2006;6:282.","DOI":"10.1186\/1471-2458-6-282"},{"issue":"5","key":"1955_CR54","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/jgs.12204","volume":"61","author":"RR Kalyani","year":"2013","unstructured":"Kalyani RR, Tra Y, Yeh HC, Egan JM, Ferrucci L, Brancati FL. Quadriceps strength, quadriceps power, and gait speed in older U.S. adults with diabetes mellitus: results from the national health and nutrition examination survey, 1999\u20132002. J Am Geriatr Soc. 2013;61(5):769\u201375.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1955_CR55","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.physbeh.2008.01.020","volume":"94","author":"E Phielix","year":"2008","unstructured":"Phielix E, Mensink M. Type 2 diabetes mellitus and skeletal muscle metabolic function. Physiol Behav. 2008;94(2):252\u20138.","journal-title":"Physiol Behav"},{"key":"1955_CR56","doi-asserted-by":"crossref","unstructured":"Kwon HS, Hwang M, Koh S-H, Choi SH, Lee J-H, Kim H-J, et al. Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients. Sci Rep. 2025;15(1):7791.","DOI":"10.1038\/s41598-025-90232-8"},{"key":"1955_CR57","doi-asserted-by":"crossref","unstructured":"Sarto J, Esteller-Gauxax D, Guill\u00e9n N, Falg\u00e0s N, Borrego-\u00c9cija S, Massons M, et al. Accuracy and clinical applicability of plasma tau 181 and 217 for Alzheimer\u2019s disease diagnosis in a memory clinic cohort. J Neurol. 2025;272(2):160.","DOI":"10.1007\/s00415-025-12897-5"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01955-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01955-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01955-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:07:42Z","timestamp":1789398462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01955-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1955"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01955-5","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"National Center for Geriatrics and Gerontology (NCGG), the employer of Dr. Akinori Nakamura, has filed and registered the following patents: AU 2016322342, AU 2019205010, CN 201680053338.0, EP 16846400.6, EP 19192797.9, IN 201847013746, JP 6467512, and US 15\/752498. Dr. Akinori Nakamura is the inventor of these patents, but all patent rights have been transferred to NCGG. The authors report no competing interests regarding this research.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}